Clinical Trial

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 18, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients with CP and may eventually be able to predict response to invasive CP therapies.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2018-02-08; most recent amendment 2025-12-16.
Trial Details
NCT Number NCT03434392
Lead Sponsor Anna Evans Phillips
Collaborators: Johns Hopkins University, Aalborg University
Conditions Chronic Pancreatitis, Chronic Pain
Enrollment 500 participants
Start Date 2017-10-24
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-18